Breaking News

PPD Appoints Corporate Development SVP

April 22, 2014

De Silva brings 15 years of biopharma experience

Bhooshi De Silva has been appointed senior vice president of corporate development and strategy at PPD, and joins the executive leadership team. Mr. De Silva will focus on key strategic initiatives to support growth, including corporate development, strategy and mergers and acquisitions.
 
Mr. De Silva has 15 years of experience in the biopharma industry and has served in leadership roles. He began his career at Pfizer, serving in roles across the R&D and commercial organizations in portfolio management, strategy and operations. His responsibilities included overseeing the development and strengthening of analytical frameworks and decision-making processes. Most recently, he served as head of business development, corporate strategy and international teams at Optimer Pharmaceuticals.
 
“Bhooshi’s vision and expertise will be invaluable in our efforts to grow our business and successfully meet the evolving needs of our clients,” said David Simmons, PPD’s chairman and chief executive officer. “He comes to PPD well-prepared to help us navigate the challenges of the changing biopharmaceutical landscape, while developing and executing a strategy for our company’s continued success.”
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.